McKesson Corporation Company Profile (NYSE:MCK)

McKesson Corporation trades on the New York Stock Exchange (NYSE) under the ticker symbol "MCK."

McKesson Corporation announced a quarterly dividend on Wednesday, May 24th. Stockholders of record on Monday, June 5th will be given a dividend of $0.28 per share on Monday, July 3rd. This represents a $1.12 annualized dividend and a dividend yield of 0.67%. The ex-dividend date of this dividend is Thursday, June 1st. View McKesson Corporation's Dividend History.

McKesson Corporation (NYSE:MCK) announced its earnings results on Thursday, May, 18th. The company reported $3.39 earnings per share for the quarter, beating analysts' consensus estimates of $3.04 by $0.35. The firm had revenue of $48.71 billion for the quarter, compared to analyst estimates of $49.48 billion. McKesson Corporation had a net margin of 2.55% and a return on equity of 29.99%. McKesson Corporation's revenue was up 4.4% on a year-over-year basis. During the same period last year, the business posted $2.44 EPS. View McKesson Corporation's Earnings History.

16 equities research analysts have issued 1-year target prices for McKesson Corporation's shares. Their predictions range from $131.00 to $193.00. On average, they expect McKesson Corporation's share price to reach $169.50 in the next year. View Analyst Ratings for McKesson Corporation.

Here are some recent quotes from research analysts about McKesson Corporation stock:

• 1. According to Zacks Investment Research, "Over the past three months, McKesson has been trading above the broader Medical/Dental – Supplies industry. Looking forward, management expects to gain with the gradually stabilizing generic and branded markets. The company recently posted stable numbers for the fourth-quarter fiscal 2017 (ended Mar 31, 2017) wherein earnings beat the Zacks Consensus Estimate, courtesy of a strong performance in the Distribution Solutions division. To boost growth the company has acquired CoverMyMeds for approximately $1.1 billion in the recent past. Also, cost-savings efforts remain encouraging. Furthermore, an inexpensive valuation and rising estimate revision trend for the current year indicates a pocket of opportunity for the stock. On the flip side, stiff competition, currency headwind and reimbursement issues remain challenges." (7/12/2017)
• 2. Citigroup Inc. analysts commented, "MCK yesterday announced the completion of its previously-announced agreement w/Change Healthcare (CHC) to create a new HCIT company retaining the same name, combining substantially all of CHC's business and the majority of MCK Tech. Solutions, less its EIS segment which will remain in MTS. Initial plans to merge assets were announced on 6/28/16. Mgmt provided color on the NewCo's financial implications, largely consistent with expectations, with recognition occurring on a 1-month lag (reducing guided F4Q17 adj EPS by ~$0.15). We update our estimates to fully reflect today's guidance on the NewCo, but currently assume a full FY18 RAD contribution to MCK. Net, we maintain our Buy, as headwinds appear to be stabilizing while the WMT contract should improve purchasing power, with some offsets given initial Change dilution and a likely F2H18 loss of RAD; $175 TP (+$6), ~13-14x CY17 EPS, ~17% ETR." (3/6/2017)

Some companies that are related to McKesson Corporation include Thermo Fisher Scientific (TMO), Biogen (BIIB), Stryker Corporation (SYK), Regeneron Pharmaceuticals (REGN), Aetna (AET), Shire PLC (SHPG), Anthem (ANTM), Fresenius SE (FSNUY), Becton, Dickinson and Company (BDX), Vertex Pharmaceuticals Incorporated (VRTX), Takeda Pharmaceutical (TKPYY), Express Scripts Holding Company (ESRX), Boston Scientific Corporation (BSX), Intuitive Surgical (ISRG), Humana (HUM), Teva Pharmaceutical Industries Limited (TEVA), Baxter International (BAX) and Zoetis (ZTS).

McKesson Corporation's management team includes the folowing people:

• John Harvey Hammergren, Chairman of the Board, President, Chief Executive Officer
• James A. Beer, Chief Financial Officer, Executive Vice President
• Kathleen D. McElligott, Executive Vice President, Chief Technology Officer, Chief Information Officer
• Lori Ann Schechter, Executive Vice President, Chief Compliance Officer, General Counsel
• Jorge L. Figueredo, Executive Vice President - Human Resources
• Paul Coleman Julian, Executive Vice President, Group President
• Bansi Nagji, Executive Vice President - Corporate Strategy and Business Development
• Edward A. Mueller, Lead Independent Director
• Andrew D. Bryant, Independent Director
• Wayne A. Budd, Independent Director

McKesson Corporation's stock is owned by a number of of institutional and retail investors. Top institutional investors include Hexavest Inc. (0.20%), Factory Mutual Insurance Co. (0.17%), PGGM Investments (0.16%), Strs Ohio (0.16%), Bank of Montreal Can (0.14%) and APG Asset Management N.V. (0.13%). Company insiders that own McKesson Corporation stock include Erin M Lampert, James A Beer, John H Hammergren, Lori A Schechter, M Christine Jacobs, Marie L/Ca Knowles, Nigel A Rees, Patrick Blake, Paul C Julian, Susan R Salka and Wayne A Budd. View Institutional Ownership Trends for McKesson Corporation.

McKesson Corporation's stock was sold by a variety of institutional investors in the last quarter, including First Quadrant L P CA, CWM LLC, Strs Ohio, APG Asset Management N.V., Grimes & Company Inc., Hexavest Inc., US Bancorp DE and PGGM Investments. Company insiders that have sold McKesson Corporation stock in the last year include Erin M Lampert, John H Hammergren, M Christine Jacobs, Marie L/Ca Knowles and Wayne A Budd. View Insider Buying and Selling for McKesson Corporation.

McKesson Corporation's stock was purchased by a variety of institutional investors in the last quarter, including Adams Diversified Equity Fund Inc., Affinity Investment Advisors LLC, ING Groep NV, Russell Investments Group Ltd., Mn Services Vermogensbeheer B.V., Bank of Montreal Can, Meag Munich Ergo Kapitalanlagegesellschaft MBH and National Pension Service. Company insiders that have bought McKesson Corporation stock in the last two years include Lori A Schechter and Susan R Salka. View Insider Buying and Selling for McKesson Corporation.

Shares of McKesson Corporation can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of McKesson Corporation stock can currently be purchased for approximately $166.35.